Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution.

ObjectManagement of unruptured arteriovenous malformations (AVMs) is controversial. In the first randomized trial of unruptured AVMs (A Randomized Trial of Unruptured Brain Arteriovenous Malformations [ARUBA]), medically managed patients had a significantly lower risk of death or stroke and had better outcomes. The University of California, San Francisco (UCSF) was one of the participating ARUBA sites. While 473 patients were screened for eligibility, only 4 patients were enrolled in ARUBA. The purpose of this study is to report the treatment and outcomes of all ARUBA-eligible patients at UCSF... Mehr ...

Volltext
Verfasser: Rutledge, W Caleb
Abla, Adib A
Nelson, Jeffrey
Halbach, Van V
Kim, Helen
Lawton, Michael T
Dokumenttyp: Artikel
Erscheinungsdatum: 2014
Reihe/Periodikum: Neurosurgical FOCUS, vol 37, iss 3
Verlag/Hrsg.: eScholarship
University of California
Schlagwörter: Biomedical and Clinical Sciences / Clinical Sciences / Stroke / Clinical Trials and Supportive Activities / Brain Disorders / Clinical Research / Neurosciences / Adolescent / Adult / Aged / Embolization / Therapeutic / Humans / Intracranial Arteriovenous Malformations / Kaplan-Meier Estimate / Magnetic Resonance Angiography / Magnetic Resonance Imaging / Male / Middle Aged / Postoperative Complications / Radiosurgery / Retrospective Studies / Tomography Scanners / X-Ray Computed / Treatment Outcome / Young Adult / arteriovenous malformation / ARUBA / observation / microsurgical resection / ARUBA = A Randomized Trial of Unruptured Brain Arteriovenous Malformations / AVM = arteriovenous malformation / UCSF = University of California / San Francisco / mRS = modified Rankin Scale / Neurology & Neurosurgery
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-26485798
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://escholarship.org/uc/item/6nc4023r